| Serial Number | 97785396 |
| Word Mark | TIBEO |
| Filing Date | Wednesday, February 8, 2023 |
| Status | 653 - SUSPENSION LETTER - MAILED |
| Status Date | Thursday, August 29, 2024 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | NOT AVAILABLE |
| Goods and Services | Pharmaceutical preparations for the treatment of cancer, and autoimmune diseases |
| Goods and Services | Scientific and medical research and development in the field of cancer and autoimmune disease research and pharmaceutical drug development; medical research laboratory services in the field of oncology and autoimmune disease, drug development, biotechnology development, drug development services; pharmaceutical drug development services in the field of oncology and autoimmune diseases; scientific research and development services in the field of cancer, oncology and autoimmune diseases; scientific research for medical purposes in the field of cancerous and autoimmune diseases; clinical research in the field of cancer, oncology and autoimmune diseases; research and development services in the field of drug development for cancer and autoimmune diseases; providing an online non-downloadable computer software platform for medical research, pharmaceutical drug discovery and pharmaceutical drug development; Pharmaceutical product research and development for cancer, oncology and autoimmune diseases; Research and development of medicines and pharmaceutical preparations for the treatment of cancer and autoimmune diseases; Scientific and technological services, namely, scientific research and development of pharmaceutical drugs for the treatment of cancer and autoimmune diseases in the field of medicine; scientific laboratory services; Testing, inspection or research of pharmaceuticals |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, February 27, 2023 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, February 27, 2023 |
| Primary Code | 042 |
| First Use Anywhere Date | Tuesday, March 1, 2022 |
| First Use In Commerce Date | Tuesday, March 1, 2022 |
| Party Name | Jubilant Therapeutics Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Bedminster, NJ 07921 |
| Event Date | Event Description |
| Saturday, February 11, 2023 | NEW APPLICATION ENTERED |
| Monday, February 27, 2023 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Tuesday, November 7, 2023 | ASSIGNED TO EXAMINER |
| Wednesday, November 8, 2023 | NON-FINAL ACTION WRITTEN |
| Wednesday, November 8, 2023 | NON-FINAL ACTION E-MAILED |
| Wednesday, November 8, 2023 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Monday, February 5, 2024 | APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED |
| Monday, February 5, 2024 | APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED |
| Tuesday, May 7, 2024 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Tuesday, May 7, 2024 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Tuesday, May 7, 2024 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Thursday, August 29, 2024 | LETTER OF SUSPENSION E-MAILED |
| Thursday, August 29, 2024 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED |
| Thursday, August 29, 2024 | SUSPENSION LETTER WRITTEN |